• RUS
  • UKR
  • ENG
  • KZ
  • ESP
  • FR
telegram
Treatments
Oncology
Doctors
  • RUS
  • UKR
  • ENG
  • KZ
  • ESP
  • FR
telegram
Associate Professor Yasin Kutlu

Associate Professor Yasin Kutlu

Medical Oncologist
icon
Istanbul, Turkey
icon
Clinical experience: 15 years
Languages: EnglishTürkçe
Medical Oncologist
icon
Clinical experience: 15 years

Associate Professor Yasin Kutlu is a medical oncologist and faculty member at the medical school, seeing patients at Medipol Mega University Hospital in Istanbul. The doctor specializes in the medicinal treatment of solid tumors and develops an individualized therapy plan considering the tumor type, disease stage, molecular characteristics, and the patient’s general condition.

Conditions treated by Associate Professor Yasin Kutlu

  • breast cancer;
  • lung cancer;
  • stomach, colon, and rectal cancer;
  • prostate and testicular cancer;
  • ovarian and endometrial cancer;
  • kidney and bladder cancer.

During the consultation, the doctor reviews histological reports, imaging and laboratory results, and information about previous treatments. After evaluating the data, he discusses with the patient the possible sequence of drug therapy and the need for a joint decision with surgeons, radiation oncologists, radiologists, and other specialized professionals. The final treatment plan is determined individually.

The doctor graduated from Trakya University Faculty of Medicine in 2011. After mandatory public service, he specialized in internal medicine at Okmeydanı Training and Research Hospital. In 2020, ranking 10th in Turkey on the YDUS exam, he began an additional specialization in medical oncology at Medipol Mega and completed it in 2023. In 2025, he received the title of Associate Professor of Medical Oncology.

The doctor’s scientific activity is related to personalized cancer treatment and the search for factors influencing treatment effectiveness. He has researched HER2 loss after neoadjuvant breast cancer treatment, immuno- and chemoimmunotherapy for lung cancer, treatment of triple-negative breast cancer, the use of nivolumab in stomach and gastroesophageal junction tumors, and prognostic markers in prostate and colorectal cancer. The AVESIS university system lists 20 scientific articles, including publications in international peer-reviewed journals and multicenter studies by the Turkish Oncology Group.

Why patients choose Associate Professor Yasin Kutlu

  • specialization in internal medicine and medical oncology;
  • experience in treating major types of solid tumors;
  • participation in multicenter clinical trials;
  • membership in ASCO, ESMO, and TTOD;
  • proficiency in English for consultations.

To consult and receive treatment from Associate Professor Yasin Kutlu, please submit an application on the website. Experts Medical coordinating doctors will help you transfer medical documents, obtain a preliminary opinion, arrange an appointment date, and organize your trip to Turkey.

Achievements and Awards

Associate Professor of Medical Oncology since 2025
10th place in Turkey on the YDUS exam
Author and co-author of 20 scientific articles
14 publications indexed in SCI-E, SSCI, AHCI
Participant in TOG multicenter studies
Member of ASCO, ESMO, and TTOD
Coordinator of two TOG multicenter lung cancer studies
Author of two chapters on immunotherapy side effects

About Dr. Yasin Kutlu

Specialization
  • Medical Oncology and medicinal treatment of solid tumors
  • Breast and lung cancer
  • Stomach, colon, and rectal cancer
  • Prostate, testicular, kidney, and bladder cancer
  • Ovarian and endometrial cancer
Education
  • 2011 — Faculty of Medicine, Trakya University
  • 2013–2018 — Internal Medicine Specialization, University of Health Sciences Okmeydanı Training and Research Hospital
  • 2020–2023 — Medical Oncology Subspecialty, Medipol Mega University Hospital
  • 2025 — Associate Professor of Medical Oncology
Clinical Experience
  • 2011–2013 — Compulsory Service Physician, Bahçelievler Tuberculosis Dispensary
  • 2013–2018 — Internal Medicine Resident, Okmeydanı Training and Research Hospital
  • 2018–2020 — Internal Medicine Specialist, Almus State Hospital, Tokat
  • 2020–2023 — Medical Oncology Subspecialty Physician, Medipol Mega University Hospital
  • 2023–2025 — Medical Oncologist, Tokat State Hospital
  • Since 2025 — Lecturer and Medical Oncologist, Medipol Mega University Hospital
Scientific Activity

Associate Professor Yasin Kutlu’s scientific activity focuses on personalized drug treatment of solid tumors and the search for factors that predict treatment effectiveness.

  • Immunotherapy, chemoimmunotherapy, and targeted therapy for lung cancer
  • HER2-positive, triple-negative, and hormone-dependent breast cancer
  • Treatment of gastric, esophageal, and gastroesophageal junction cancer
  • Prognostic markers for prostate and colorectal cancer
  • PET-CT in pancreatobiliary tumors
  • HER2, PD-L1, SPARC, MMR/CDX2, and inflammatory markers

His work is based on multicenter real-world clinical practice studies. He participates in projects of the Turkish Oncology Group (TOG) and coordinates two multicenter studies on the treatment of non-small cell lung cancer. He is the author of two chapters on the diagnosis and treatment of endocrine and hepatic complications of immunotherapy.

The AVESIS system presents 20 articles: 14 are indexed in SCI-E, SSCI, or AHCI, 17 in Scopus, and 4 in TRDizin. The works are published in Cancers, Current Problems in Cancer, Medicine, International Immunopharmacology, International Journal of Clinical Oncology, and other peer-reviewed journals.

Membership in Associations
  • Turkish Society of Medical Oncology (TTOD)
  • American Society of Clinical Oncology (ASCO)
  • European Society for Medical Oncology (ESMO)
Medipol Mega University Hospital
Clinic where the doctor consults
Medipol Mega University Hospital
icon
Turkey, Istanbul

Medipol Mega University Hospital is a multidisciplinary university complex in the Bağcılar district of Istanbul, operating since 2012. Its structure includes a specialized oncology hospital. According to Medipol, the complex brings together academic specialists from various fields and provides medical care 24/7.

Associate Professor Yasin Kutlu consults in the Department of Medical Oncology. Here, patients with breast, lung, stomach, intestinal, genitourinary, and gynecological cancers can receive consultation, evaluation of biopsy results, laboratory tests, and imaging, as well as an individualized drug treatment plan. If necessary, the clinical case is reviewed jointly with surgeons, radiation oncologists, radiologists, and other specialists.

The complex has 810 beds, 215 intensive care units, 358 outpatient clinics, and 25 operating rooms. The infrastructure allows for diagnosis, treatment, and follow-up in one medical center. The hospital has international JCI accreditation.

Published 27.09.2026
Dr Nataliia
Hello, I am a doctor. Do you have any question regarding the procedure?
Ask question to the doctor!